Drug intelligence / Profile preview

adapalene + benzoyl peroxide

Development stage
Approved
Lead developer
Galderma
Modality
Small Molecules
Administration
Topical
01

Overview

Adapalene + benzoyl peroxide is a fixed-dose **topical combination** acne therapy composed of adapalene, a third-generation retinoid, and benzoyl peroxide, an oxidizing antimicrobial and keratolytic agent. It is marketed as gels including **Epiduo** and **Epiduo Forte** and is indicated for the topical treatment of **acne vulgaris**. The combination is designed to address complementary pathogenic drivers of acne: adapalene modulates retinoid-responsive pathways that normalize follicular keratinization and reduce inflammatory signaling, while benzoyl peroxide exerts bactericidal activity against *Cutibacterium acnes* and helps reduce comedones and inflammatory lesions. Public sources including FDA labeling, DailyMed listings, and ClinicalTrials.gov records verify the product and its development and marketed use in acne vulgaris.

Brand names
EpiduoEpiduo ForteDifferin Epiduo Acne Gel
Other names
adapalene and benzoyl peroxideadapalene and benzoyl peroxide topical geladapalene-benzoyl peroxideadapalene + benzoyl peroxide
02

Targets

RARG (Retinoic acid receptor gamma)RARB (Retinoic acid receptor beta)

Beyond the preview

Go deeper on adapalene + benzoyl peroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adapalene + benzoyl peroxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call